mRNA |
KU 0060648 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0003 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0006 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.001 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.002 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.004 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.004 |
mRNA |
bendamustine |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.008 |